Tag: biomedical
-
Shire Licensing Dry Eye Disease Treatment in $535M Deal
An experimental drug for treating dry eye disease, a common disorder affecting older individuals, is being licensed by international pharmaceutical company Shire plc.
-
$175K Challenge Seeks New Antimicrobial Preservatives
A new challenge competition on InnoCentive is seeking development of new types of preservatives for personal care and other household products.
-
Crispr, Stem Cells Produce Precise Arthritis Therapy
Editing the genes in stem cells is shown to produce cartilage that in lab tests releases therapeutic proteins only when needed to relieve joint inflammation in arthritis.
-
Muscle Supplement Shown Safe, Active in Elderly
A clinical trial testing a dietary supplement to improve muscle function in older persons shows the derivative from pomegranates is safe and produces desired biological actions.
-
Smartphone-Controlled Cells Produce Insulin on Demand
A system designed by researchers in China and Switzerland and controlled by a smartphone app was shown in lab mice to produce insulin on demand from engineered pancreas cells.
-
FDA Warns Cancer Fraud Product Providers
The Food and Drug Administration sent warning letters to 14 companies in the U.S. that the agency says are selling products fraudulently claiming to prevent, diagnose, treat, or cure cancer.
-
Nanoparticle Vaccine Stops Tumor Growth
Researchers in Texas designed a cancer vaccine with nanoscale particles that in lab mice stimulates the immune system and stops the growth of several types of tumors.
-
Plant-Based Drug Shown to Cure Drug-Resistant Malaria
An experimental drug made from dried Artemisia annua plant leaves cured patients in Africa with malaria infections that became resistant to current drugs.
-
Compound Found to Prevent Asthma Inflammation
A research team in Cincinnati discovered a small-molecule drug compound that in lab mice prevents cells in the lungs from becoming inflamed, as occurs in asthma attacks.
-
Vaccine R&D Underway to Protect Against Animal Microbes
Research is underway in the U.K. on development of new vaccines to protect humans against zoonotic diseases, infectious diseases originating in animals.